Recruiting
Phase 2

Pembrolizumab & Lenvatinib

Sponsor:

Georgetown University

Code:

NCT04865887

Conditions

Cervical Cancer

Metastatic Cervical Cancer

Eligibility Criteria

Sex: Female

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Pembrolizumab

Lenvatinib

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-08-25. This information was provided to ClinicalTrials.gov by Georgetown University on 2025-10-07.